About Andrew King
Andrew King is a director of Crosslink Therapeutics Inc., which develops cancer medicines for solid tumors.
Experience
This experience comes from Andrew King's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andrew King in the role, so the role may have started earlier or lasted longer.
Crosslink Therapeutics Inc. Current
Director
2025 – Present · Boston, MA
Crosslink builds a modular biologic platform for antibody-drug conjugates and radioligand therapies.
CV
Cure Ventures Current
Partner and Chief Financial Officer
2021 – Present
BC
Bain Capital
Vice President
2012 – 2021
EY
Ernst & Young
Manager
2005 – 2012
Key Colleagues at Startups
The people Andrew King works with at each company, as listed on that company's latest Form D.
Crosslink Therapeutics Inc. · Form D, Oct 20, 2026
RI
Ronald Seidel, III
Co-founder and CEO, director
Lou Tartaglia
Director
Rodolfo Chaparro
Co-Founder and Scientific Advisor, director
David Fallace
Director
Cameron Gallagher
Chairman